---
title: Barbera Landing Page
---

This is a search field with an auto-suggest feature attached.

- There are no suggestions because the search field is empty.

- [Careers](https://www.siegfried.ch/careers/)
- [Media](https://www.siegfried.ch/media/)
- [Investors](https://www.siegfried.ch/investors/)
- [Contact us](https://www.siegfried.ch/contact/)

[Company](https://www.siegfried.ch/company/)

Company

[Purpose](https://www.siegfried.ch/company/purpose/)

[Strategy](https://www.siegfried.ch/company/strategy/)

[Leadership](https://www.siegfried.ch/company/leadership/)

[History](https://www.siegfried.ch/company/history/)

[Locations](https://www.siegfried.ch/company/locations/)

[Offering](https://www.siegfried.ch/offering/)

Offering

[Drug Substances](https://www.siegfried.ch/offering/drug-substances/)

[Exclusive synthesis](https://www.siegfried.ch/offering/drug-substances/exclusive-synthesis/) [API portfolio](https://www.siegfried.ch/offering/drug-substances/api/) [Reference standards](https://www.siegfried.ch/reference-standards/) [Preclinical and early-phase development](https://content.siegfried.ch/siegfried-acceleration-hub?hsLang=en) [Alkaloid raw materials extraction](https://extractas.com.au/)

[Drug Products](https://www.siegfried.ch/offering/drug-products/)

[Oral solid dosage forms](https://www.siegfried.ch/offering/drug-products/oral-solids/) [Sterile injectables](https://www.siegfried.ch/offering/drug-products/sterile-injectables/) [Ophthalmics](https://www.siegfried.ch/offering/drug-products/ophthalmics/) [Inhalation products](https://www.siegfried.ch/offering/drug-products/inhalatives/) [Viral vectors](https://dinamiqs.com/)

[Technologies](https://www.siegfried.ch/technologies/)

[Sustainability](https://www.siegfried.ch/sustainability/)

Sustainability

[People](https://www.siegfried.ch/sustainability/people/)

[Environment](https://www.siegfried.ch/sustainability/environment/environment/)

[Integrity](https://www.siegfried.ch/sustainability/integrity/)

[Quality](https://www.siegfried.ch/sustainability/quality/)

[Community engagement](https://siegfried.ch/sustainability/community-engagement/)

[Risk management](https://www.siegfried.ch/sustainability/risk-management/)

[Insights](https://content.siegfried.ch/insights?hsLang=en)

[![](https://content.siegfried.ch/hubfs/siegfried-logo.svg)](https://www.siegfried.ch/)

What are you  
looking for?

[![](https://content.siegfried.ch/hubfs/siegfried-logo.svg)](https://www.siegfried.ch/)

[Company](https://www.siegfried.ch/company/)

[Purpose](https://www.siegfried.ch/company/purpose/)

[Strategy](https://www.siegfried.ch/company/strategy/)

[Leadership](https://www.siegfried.ch/company/leadership/)

[History](https://www.siegfried.ch/company/history/)

[Locations](https://www.siegfried.ch/company/locations/)

[Offering](https://www.siegfried.ch/offering/)

[Drug Substances](https://www.siegfried.ch/offering/drug-substances/)

[Exclusive synthesis](https://www.siegfried.ch/offering/drug-substances/exclusive-synthesis/) [API portfolio](https://www.siegfried.ch/offering/drug-substances/api/) [Reference standards](https://www.siegfried.ch/reference-standards/) [Preclinical and early-phase development](https://content.siegfried.ch/siegfried-acceleration-hub?hsLang=en) [Alkaloid raw materials extraction](https://extractas.com.au/)

[Drug Products](https://www.siegfried.ch/offering/drug-products/)

[Oral solid dosage forms](https://www.siegfried.ch/offering/drug-products/oral-solids/) [Sterile injectables](https://www.siegfried.ch/offering/drug-products/sterile-injectables/) [Ophthalmics](https://www.siegfried.ch/offering/drug-products/ophthalmics/) [Inhalation products](https://www.siegfried.ch/offering/drug-products/inhalatives/) [Viral vectors](https://dinamiqs.com/)

[Technologies](https://www.siegfried.ch/technologies/)

[Sustainability](https://www.siegfried.ch/sustainability/)

[People](https://www.siegfried.ch/sustainability/people/)

[Environment](https://www.siegfried.ch/sustainability/environment/environment/)

[Integrity](https://www.siegfried.ch/sustainability/integrity/)

[Quality](https://www.siegfried.ch/sustainability/quality/)

[Community engagement](https://siegfried.ch/sustainability/community-engagement/)

[Risk management](https://www.siegfried.ch/sustainability/risk-management/)

[Insights](https://content.siegfried.ch/insights?hsLang=en)

- [Careers](https://www.siegfried.ch/careers/)
- [Media](https://www.siegfried.ch/media/)
- [Investors](https://www.siegfried.ch/investors/)
- [Contact us](https://www.siegfried.ch/contact/)

[Home](https://www.siegfried.ch/) / [Barberà del Vallès](https://content.siegfried.ch/barbera)

# **Barberà del Vallès**

Located near Barcelona, the Barber site offers development and manufacturing services for complex oral solid dosage forms and inhalation products, from early-phase development to commercial manufacturing and packaging. 

[Get in touch](https://www.siegfried.ch/contact-us/)

![Siegfried-checkbox-icon-navy-new](https://content.siegfried.ch/hubfs/Icons/Siegfried-checkbox-icon-navy-new.svg)

#### Oral solid dosage forms

We offer end-to-end services for the most complex oral solid dosage forms, from early-phase development to commercial manufacturing and packaging.

![Siegfried-checkbox-icon-navy-new](https://content.siegfried.ch/hubfs/Icons/Siegfried-checkbox-icon-navy-new.svg)

#### High potency (HIPO)

Our offering includes services for highly potent products with an OEL of \<1 mg/m3 for customers worldwide, including the US and Japan as well as Europe.

![Siegfried-checkbox-icon-navy-new](https://content.siegfried.ch/hubfs/Icons/Siegfried-checkbox-icon-navy-new.svg)

#### Inhalation products

We specialize in high-containment inhalation manufacturing, including advanced product dispensing, capsule filling, and state-of-the-art packaging.

## Our team of experts accelerates complex projects from development to commercial

At our cutting-edge development and manufacturing site in Barberà del Vallès in Barcelona, Spain, our experienced team accelerates your path to market from early-phase to high volume commercial manufacturing.

[Get in touch with our experts](https://www.siegfried.ch/contact-us/)

<iframe src="https://player.vimeo.com/video/688015417?badge=0&amp;autopause=0&amp;player_id=0&amp;app_id=58479" frameborder="0" allow="autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media" style="position:absolute;top:0;left:0;width:100%;height:100%;border-radius:0;" title="INTRODUCTION_BARBERA"></iframe>

![Siegfried-lighbulb-icon-navy-new](https://content.siegfried.ch/hubfs/Siegfried-lighbulb-icon-navy-new.svg)

### More than 30 years of expertise

Our experienced team solves your most complex projects.

![Siegfried-process-development-icon-navy](https://content.siegfried.ch/hubfs/Siegfried-process-development-icon-navy.svg)

### From early-phase to commercial

We provide you with seamless support from early phase to commercial scale.

![Siegfried-clock-icon-navy](https://content.siegfried.ch/hubfs/Siegfried-clock-icon-navy.svg)

### Accelerating speed to market

We accelerate your development and ensure fast tech transfers.

### Our technologies and capabilities

 Spray drying

 Serialization and aggregation

 Printing on demand

 Blending

 Wallet secondary packaging

 Dry and wet granulation

 Capsule filling

 Tabletting

 Film coating

 Blistering

## Development expertise for complex drug products

Our state-of-the-art Development Center provides you with a wide range of development and scale-up services as well as flexible pilot capacities.

**Would you like to learn more?**

[Get in touch](https://www.siegfried.ch/contact-us/)

![20230424\_Siegfried\_Barcelona18803\_300ppi\_RGB\_RZ (1)-1](https://content.siegfried.ch/hs-fs/hubfs/20230424_Siegfried_Barcelona18803_300ppi_RGB_RZ%20(1)-1.jpg?width=640&height=427&name=20230424_Siegfried_Barcelona18803_300ppi_RGB_RZ%20(1)-1.jpg)

![Siegfried-checkbox-icon-navy-new](https://content.siegfried.ch/hubfs/Siegfried-checkbox-icon-navy-new.svg)

### Formulation, process & analytical development, scale-up, clinical trial manufacturing & transfer.

![Siegfried-checkbox-icon-navy-new](https://content.siegfried.ch/hubfs/Siegfried-checkbox-icon-navy-new.svg)

### State-of-the-art development and pilot area (GMP). Batch size from \<1kg.

![Siegfried-checkbox-icon-navy-new](https://content.siegfried.ch/hubfs/Siegfried-checkbox-icon-navy-new.svg)

### Dedicated HIPO area for development of drug products containing highly potent APIs (\<1 mg/m3 –OEB5).

![Siegfried-checkbox-icon-navy-new](https://content.siegfried.ch/hubfs/Siegfried-checkbox-icon-navy-new.svg)

### End-to-end service from development to commercial production with standardized processes and equipment.

 expect more

**Siegfried AG**

Untere Brühlstrasse 4  
4800 Zofingen, Switzerland

[+41 62 746 11 11](tel:+41627461111) [Get in touch](https://www.siegfried.ch/contact-us/)

#### About us

- [Our company](https://www.siegfried.ch/company/)
- [Sustainability](https://www.siegfried.ch/sustainability/)
- [Media](https://www.siegfried.ch/media/)
- [Investors](https://www.siegfried.ch/investors/)
- [Careers](https://www.siegfried.ch/careers/)

#### Helpful resources

- [Expert insights](https://content.siegfried.ch/insights?hsLang=en)
- [News archive](https://www.siegfried.ch/news-archive/)
- [Reports](https://www.siegfried.ch/investors/investors-download-center-2025/)
- [Terms and conditions](https://www.siegfried.ch/terms-and-conditions/)

#### Offering

- [Drug Substances](https://www.siegfried.ch/offering/drug-substances/)
- [Drug Products](https://www.siegfried.ch/offering/drug-products/)
- [Technologies](https://www.siegfried.ch/technologies/)

2026 © Siegfried Holding AG

<https://www.linkedin.com/company/50322/admin/feed/posts/>

- [Privacy Policy](https://www.siegfried.ch/privacy-policy/)
- [Legal disclaimer](https://www.siegfried.ch/legal-disclaimer/)
- [Imprint](https://www.siegfried.ch/imprint/)